Archives of Clinical Ophthalmology

Editorial Open Access

Mega-Dose Dietary Riboflavin in Treatment in Keratoconus, Post-Refractive Cornea Ectasia and Migraine. Has Its Time Arrived?

John Steven Jarstad

Recently, several studies and investigators have shown the beneficial effects of high dose dietary riboflavin (vitamin B2) in the treatment of keratoconus, post-refractive (LASIK, PRK & Radial Keratotomy) ectasia (with sunlight exposure) and patients treated with our own protocol (NIH Clinical Study – www.clinicaltrials.gov - # NCT 03095235) discovered significant relief for intractable migraine headaches and/or ophthalmic migraine (classic migraine visual symptoms without headache).

Arch Clin Ophthalmol, 2021, Volume 1, Issue 1, p20-20 | DOI: 10.33696/Ophthalmology.1.003

Commentary Open Access

Multidisciplinary Acute Care of Central Retinal Artery Occlusion with a Stroke Paradigm: A Call to Action

Stacey Q. Wolfe , Stephanie A. Coffman , Mark Perez , Katriel Lee , Bartlett H.Hayes , Tamra Ranasinghe , Patrick A. Brown , Kyle M. Fargen

Central retinal artery occlusion (CRAO) is an ophthalmologic emergency that can result in permanent vision loss. Over 25% of CRAO are associated with acute cerebral ischemia, and there are many parallels between CRAO and acute ischemic stroke. There are no definitive treatment algorithms for CRAO, however there may be opportunities to treat CRAO as an “eye stroke”. Given the similarities to acute ischemic stroke, multidisciplinary involvement and stroke algorithms should be considered and tested for this disease.

Arch Clin Ophthalmol, 2021, Volume 1, Issue 1, p20-26 | DOI: 10.33696/Ophthalmology.1.004

Commentary Open Access

Generating Awareness and a Planned Multidisciplinary Treatment Approach Can Save Both the Sight and Life in Retinoblastoma in Developing Countries

Soma Rani Roy

While rare, retinoblastoma is the most common (1:16000 – 18000 live births) intraocular and life threatening tumor of childhood. According to the World Health Organization (WHO), 66% of children present with symptoms before 2 years of age and 95% before 5 years of age. About 8000 new cases are detected annually with the highest incidence in Africa and India. In fact, more than 1400 cases each year are from India. According to Mukesh et al., 43% of the global burden lives in 6 countries of Asia (India, China, Indonesia, Pakistan, Bangladesh & Philippines).

Arch Clin Ophthalmol, 2021, Volume 1, Issue 1, p27-29 | DOI: 10.33696/Ophthalmology.1.005